Powered by

Allergan shareholders reach USD290m settlement with Valeant Pharmaceuticals and Bill Ackman's Pershing Square over insider trading claims? 

Lawyers representing shareholders of Allergan Inc have settled a lawsuit resolving insider trading claims against Valeant Pharmaceuticals International, Bill Ackman and his Pershing Square family of hedge funds stemming from Valeant's 2014 attempt to takeover Allergan.

In settling the claims, Valeant and Pershing Square agreed to jointly pay a total of USD290 million for all involved investors.

The settlement reached last week resolves both the certified stockholder class action,

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox